Navigation Links
Stem cells show promise for treating infertility in cancer patients
Date:11/1/2012

AUDIO: This is an audio clip of Deborah Sweet of Cell Stem Cell interviewing Dr. Kyle Orwig of the University of Pittsburgh School of Medicine regarding his recent preclinical study "Spermatogonial...

Click here for more information.

A promising stem-cell-based approach for treating infertility has been successfully demonstrated in non-human primates, as reported in a study published by Cell Press in the November issue of the journal Cell Stem Cell. The preclinical study represents an important milestone for translating this strategy to the clinic, particularly for cancer survivors who have been rendered infertile by chemotherapy they received before reaching sexual maturity.

"This is the first study to demonstrate that transplanted spermatogonial stem cells can produce functional sperm in higher primates," says senior study author Kyle Orwig of the University of Pittsburgh and Magee-Womens Research Institute. "This is an important step toward human translation."

Cancer patients who undergo radiation therapy or chemotherapy often become infertile because these treatments damage dividing cells, including not only cancer cells but also spermatogonial stem cells (SSCs)stem cells that develop into sperm. Prior to cancer therapy, adult men can cryopreserve their sperm and later use these cells to father children. But prepubertal boys don't have this option because they have not yet produced any mature sperm, so cancer treatments can leave them permanently infertile.

One promising strategy for these young patients is to preserve their SSCs before they undergo cancer therapy and later transplant these cells after they finish cancer treatment and reach sexual maturity. This approach has worked in a range of animal models, but past studies in large animals have primarily used radiation therapy to cause infertility, even though chemotherapy is also a common source of infertility in cancer patients.

In the new study, Orwig and his team cryopreserved SSCs from monkeys before treating them with a commonly used chemotherapy drug. After treatment, they injected the SSCs into the testes of these animals and found that the cells produced sperm in the majority of transplant recipients. Moreover, the SSC-derived sperm of one animal was capable of fertilizing egg cells and producing embryos that developed normally.

As noted in the accompanying In Translation article by Pierre Fouchet and colleagues, this work "constitutes a milestone in the field of reproduction, and generates hope for restoring fertility in survivors of childhood cancer."


'/>"/>

Contact: Elisabeth (Lisa) Lyons
elyons@cell.com
617-386-2121
Cell Press
Source:Eurekalert

Related medicine news :

1. A protein’s role in helping cells repair DNA damage
2. Scientists create endless supply of myelin-forming cells
3. Stem Cells to Cartilage? Promising Results Seen in Mice
4. Scientists decode software instructions of aggressive leukemia cells
5. New options for ease and accuracy in extraction of rare cells or separating blood
6. Stimulating brain cells with light
7. Research identifies protein that regulates key fate decision in cortical progenitor cells
8. UGA researchers boost efficacy of drugs by using nanoparticles to target powerhouse of cells
9. At the right place at the right time -- new insights into muscle stem cells
10. Lack of oxygen in cancer cells leads to growth and metastasis
11. Human Stem Cells Restore Hearing to Deaf Gerbils in Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, are big ... has been used for thousands of years. , "The West has caught on, and ... Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of the Body. ...
(Date:3/29/2017)... Wellington, Florida (PRWEB) , ... March 29, 2017 ... ... will be hosting several educational opportunities for attending prescribers at the upcoming World ... Pharmacy Network said, “A4M has always been recognized as the visionary leader in ...
(Date:3/29/2017)... ... March 29, 2017 , ... The ... a referral to new patients from Burnaby, BC. Patients in need of experienced ... reconstruction services, can see the esteemed team at Wall Centre Dental. Drs. Parviz ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... in Carnegie, OK, from Dr. Jamie Cameron, with or without a referral. ... to traditional orthodontic treatment. Depending on each patient’s case, treatment with the FASTBRACES ...
(Date:3/29/2017)... Mich. (PRWEB) , ... March ... ... and Manufacturer Alliance (GRMA) is growing as it continues developing an ANSI-approved, ... supplement industry. The organization, which plans to publish the first ANSI-approved GMP ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  The leader in accelerated ... Drs. Sam Daher , Manal Ibrahim , ... David Couchat will be the featured microlecture presenters at ... American Association of Orthodontists (AAO) Annual Session, April 21-25, ... the microlectures beginning daily at 11:20 a.m. On the ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, a ... GSP 301, an investigational fixed-dose combination of mometasone ... administered twice-daily as a nasal spray being studied ... results are from a recently completed Phase 3 ... 301 combination therapy versus mometasone, olopatadine or placebo. ...
(Date:3/29/2017)... 29, 2017 Transparency Market ... provides an exhaustive study of the U.S. substance abuse ... companies are functional in this market at present, ... leading companies, such as GlaxoSmithKline Plc., Pfizer Inc., ... on various marketing strategies to increase their visibility, ...
Breaking Medicine Technology: